Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 4
2007 6
2008 2
2009 1
2010 6
2012 3
2013 2
2014 2
2015 2
2016 3
2017 6
2018 4
2019 4
2020 1
2021 1
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
HAART in HIV/AIDS Treatments: Future Trends.
Lu DY, Wu HY, Yarla NS, Xu B, Ding J, Lu TR. Lu DY, et al. Infect Disord Drug Targets. 2018;18(1):15-22. doi: 10.2174/1871526517666170505122800. Infect Disord Drug Targets. 2018. PMID: 28474549 Review.
Ebola Therapeutic Study and Future Directions.
Lu DY, Wu HY, Yarla NS, Lu TR, Xu B, Jian-Ding. Lu DY, et al. Infect Disord Drug Targets. 2019;19(1):17-29. doi: 10.2174/1871526518666180813160348. Infect Disord Drug Targets. 2019. PMID: 30101721 Review.
Drug Combination in Clinical Cancer Treatments.
Lu DY, Lu TR, Yarla NS, Wu HY, Xu B, Ding J, Zhu H. Lu DY, et al. Rev Recent Clin Trials. 2017;12(3):202-211. doi: 10.2174/1574887112666170803145955. Rev Recent Clin Trials. 2017. PMID: 28782482 Review.
Covid-19 Study, Diagnostic and Therapeutic Transition.
Lu DY, Lu TR. Lu DY, et al. Recent Adv Antiinfect Drug Discov. 2023 Mar 31. doi: 10.2174/2772434418666230331115936. Online ahead of print. Recent Adv Antiinfect Drug Discov. 2023. PMID: 36999700
Anthocyanins: Multi-Target Agents for Prevention and Therapy of Chronic Diseases.
Putta S, Yarla NS, Peluso I, Tiwari DK, Reddy GV, Giri PV, Kumar N, Malla R, Rachel V, Bramhachari PV, Reddy D RS, Bade R, Mannarapu M, Barreto GE, Lu DY, Tarasov VV, Chubarev VN, Ribeiro FF, Scotti L, Scotti MT, Kamal MA, Ashraf GM, Aliev G, Perry G, Sarker SD, Rao CV, Bishayee A. Putta S, et al. Among authors: lu dy. Curr Pharm Des. 2017;23(41):6321-6346. doi: 10.2174/1381612823666170519151801. Curr Pharm Des. 2017. PMID: 28741457 Review.
48 results